Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

REporting recommendations for tumour MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · British Journal of Cancer · 2005 · 1.4K citations · Full text

Medicine, Biostatistics, Oncology +10

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

Richard Simon, Seungmok Paik, Daniel F. Hayes · JNCI Journal of the National Cancer Institute · 2009 · 1K citations · Full text

Medicine, Biostatistics, Oncology +17

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Paul E. Goss, James N. Ingle, José E. Alés‐Martínez et al. · New England Journal of Medicine · 2011 · 961 citations · Full text

Medicine, Oncology, Pharmacology +17

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao et al. · Journal of Clinical Oncology · 2010 · 829 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer

Katherine D. Crew, Heather Greenlee, Jillian L. Capodice et al. · Journal of Clinical Oncology · 2007 · 481 citations

Medicine, Oncology, Breast Oncology +14